Activity of N-(2-hydroxypropyl)methacrylamide copolymers containing daunomycin against a rat tumour model.
Cassidy
J
J
CRC Department of Medical Oncology, Glasgow, UK.
Duncan
R
R
Morrison
G J
GJ
Strohalm
J
J
Plocova
D
D
Kopecek
J
J
Kaye
S B
SB
D000818:Animals; D002279:Carcinoma 256, Walker / Q000188:drug therapy; D002851:Chromatography, High Pressure Liquid; D003630:Daunorubicin / Q000032:analysis / Q000493:pharmacokinetics / Q000627:therapeutic use*; D004337:Drug Carriers; D009374:Neoplasms, Experimental / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D011109:Polymethacrylic Acids / Q000493:pharmacokinetics / Q000627:therapeutic use*; D051381:Rats; D011919:Rats, Inbred Strains; D014018:Tissue Distribution
D004337:Drug Carriers; D011109:Polymethacrylic Acids; C055174:daunomycin-N-(2-hydroxypropyl)methacrylamide copolymer conjugate; D003630:Daunorubicin